Feeding kids peanuts early in childhood can drastically reduce their risk of developing a peanut allergy, a new clinical trial reports. Children regularly fed peanut products from infancy to age 5 had a 71% lower rate of peanut allergies by the time they reached their teen years, researchers reported May 28 in the journal NEJM… read on > read on >
All Food:
Binge-Eating Disorder Could Be Tougher to Kick Than Thought
Prior studies have suggested that binge eating disorder may not last long, but a more rigorous look at the illness finds that just isn’t so. “The big takeaway is that binge-eating disorder does improve with time, but for many people it lasts years,” said study first author Kristin Javaras, assistant psychologist in the Division of… read on > read on >
CDC Warns Again of Salmonella Tied to Backyard Poultry
Backyard chickens are causing outbreaks of salmonella across the United States, the U.S. Centers for Disease Control and Prevention warns. About 109 people in 29 states have gotten sick from salmonella after touching or caring for backyard poultry, the CDC said in a health advisory. Of those, 33 people have been hospitalized, the CDC said.… read on > read on >
Tea Was a Real Life Saver in 18th Century England
Sipped from porcelain cups amid the music of Mozart and periwigs of the 1700s, tea was introduced to England and began its quiet work saving thousands of lives, new research confirms. It wasn’t the leaves that kept tea drinkers out of danger: It was the boiled water tea was served in. Unboiled water had long… read on > read on >
Ozempic Lowers Odds for Death, Illness in People With Kidney Disease and Type 2 Diabetes
Ozempic provides a wide variety of health benefits for people with kidney disease and type 2 diabetes, a major clinical trial has found. The drug significantly reduces the risk of severe kidney events, heart problems and death from any cause in patients who have both conditions, researchers found. “These benefits signify a profound clinical impact… read on > read on >
Costs, Side Effects Drive Folks to Quit New Weight-Loss Meds
Three months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients have already quit the medications, and by a year from first use more than a third have stopped, new research shows. Reasons for quitting Wegovy, Ozempic or similar drugs may include cost or gastrointestinal side effects, said a… read on > read on >
Use of GLP-1 Meds Have Risen 7-Fold Among Young Americans
The number of American teens and young adults who’ve been prescribed one of the new GLP-1 weight-loss drugs soared nearly seven-fold between 2020 and 2023, a new report finds. That’s compared to an overall decline of about 3% in young Americans’ use of other types of prescription meds. But how safe are drugs like Ozempic,… read on > read on >
Do Fish Oil Supplements Help or Harm the Heart?
Folks regularly taking fish oil supplements might not be helping their health as much as they might think, a new study suggests. Regular use of fish oil supplements could increase the risk of first-time heart disease and stroke among those with good heart health, new research suggests. However, the long-term study also found that fish… read on > read on >
A Matcha Mouthwash Might Fight Gum Disease
Matcha green tea has the potential to keep gum disease at bay, a new study finds. Lab experiments show that matcha can inhibit the growth of Porphyromonas gingivalis, one of the main bacterial culprits behind gum disease. Among a small group of 45 people with gum disease, those who used matcha mouthwash wound up with… read on > read on >
‘Hungry Gut’ Gene Test Shows Who’ll Benefit Most From Wegovy
You’ve watched others shed pounds in a matter of weeks after taking one of the new blockbuster weight-loss drugs, so you decide to try one of the medications yourself, only to discover the needle on your bathroom scale barely budges. Why? New research presented Monday at the Digestive Disease Week conference in Washington, D.C., suggests… read on > read on >